Beta-blocker interruption not noninferior to continuation following myocardial infarction
1. In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy ...
1. In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy ...
1. In this prospective cohort of patients with acute myocardial infarction (AMI), plasma progranulin levels increased acutely after the AMI. ...
1. Major cardiac events were significantly lower in the OCT-guided group compared to the angiography-guided group. 2. Stroke, bleeding events, ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
1. Incidence of recurrent ischemic stroke, myocardial infarction, cardiac arrest, and hospitalization was not statistically significant between both groups. 2. ...
1. Incidence of recurrent ischemic stroke, myocardial infarction, cardiac arrest, and hospitalization was not statistically significant between both groups. 2. ...
1. Individuals with elevated fat attenuation index scores without obstructive coronary artery disease had significantly increased rates of major adverse ...
1. In this randomized controlled trial, compared to culprit-lesion-only percutaneous coronary intervention (PCI), the fractional flow reserve (FFR)-guided approach did ...
1. In this randomized controlled trial, empagliflozin was not shown to decrease the risk of hospitalization for heart failure or ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.